Introduction Interest in hormone and metabolic therapies has grown rapidly in recent years. Among the most discussed treatments are testosterone replacement therapy (TRT) and medications that activate the glucagon-like peptide-1 receptor, also called GLP-1 receptor agonists. These therapies target different but related systems in the body—hormonal balance and metabolic control. When used together under medical …